[Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer

Table 1

Comparison of general data between the two groups.

General clinical data	Control group (n = 58)	Observation group (n = 58)	t/χ^2
Age (years old)	50.06 ± 9.59	50.30 ± 9.41	0.136	0.892
Gender			0.558	0.455
Male	30	34
Female indent	28	24
Tumor location			0.666	0.415
Left	43	39
Right	15	19
Pathological grade			1.451	0.229
Moderately or highly differentiated	37	43
Poorly differentiated	21	15
Peritoneal metastasis			0.372	0.542
Yes	5	7
No	53	51